[Comparison of the effects of sugammadex and neostigmine on postoperative nausea and vomiting].
OBJECTIVE
The aim of our study is to compare the effects of sugammadex and neostigmine, used for neuromuscular blockage antagonism, on postoperative nausea and vomiting (PONV).


METHODS
Our study was completed with 98 ASA I-II risk patients undergoing endotracheal intubation under general anesthesia. At the end of the surgery patients were randomly allocated into two groups given 2mgkg-1sugammadex (Group S) or 50μgkg-1neostigmine plus 0.2mgkg-1atropine (Group N). Monitoring and recording times were set as 1 hour postoperative and from 1-6, 6-12, and 12-24hours. The anti-emetic amounts administered were recorded.


RESULTS
In the first postoperative hour 13 patients in Group N (27%) and 4 in Group S (8%) were observed to have nausea and/or vomiting and the difference was statistically significant (p=0.0016). During the 24hours of monitoring there was no significant difference in the incidence and severity of PONV (p>0.05), however the number of patients given ondansetron for PONV treatment in Group N was significantly higher than the number in Group S (16 in Group N, 6 in Group S, p<0.011).


CONCLUSIONS
At the end of our study comparing neostigmine with sugammadex for neuromuscular blockage antagonism, we found use of sugammadex had lower incidence of PONV in the postoperative 1st hour and less anti-emetic use in 24hours of monitoring.
Ordu University, School of Medicine, Department of Anesthesiology, Ordu, Turquia. Electronic address: ozguryagan@hotmail.com.
Özgür
Ö
Yağan
Ordu University, School of Medicine, Department of Anesthesiology, Ordu, Turquia.
Nilay
N
Taş
Ordu University, School of Medicine, Department of Anesthesiology, Ordu, Turquia.
Tuğçe
T
Mutlu
Dokuz Eylul University, School of Medicine, Department of Anesthesiology Alsancak, Izmir, Turquia.
Volkan
V
Hancı
D000293:Adolescent; D000328:Adult; D000368:Aged; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009388:Neostigmine / Q000627:therapeutic use*; D020250:Postoperative Nausea and Vomiting / Q000517:prevention & control*; D011446:Prospective Studies; D016037:Single-Blind Method; D000077122:Sugammadex / Q000627:therapeutic use*; D055815:Young Adult
D002800:Cholinesterase Inhibitors; D000077122:Sugammadex; D009388:Neostigmine
Nausea; Neostigmina; Neostigmine; Náusea; Postoperative; Pós‐operatório; Sugamadex; Sugammadex; Vomiting; Vômito